Conversely, increasing the expression of METTL3 might enhance the removal of phosphorylated Tau protein by autophagy and improve AD symptoms, as seen in laboratory experiments (in vitro) and animal models (in vivo) (Tang et al., 2023[126]). Here, MAPT is linked to Alzheimer disease.